Special report: aCGH for the genetic evaluation of patients with developmental delay/mental retardation or autism spectrum disorder.
D001321:Autistic Disorder / Q000175:diagnosis / Q000235:genetics*; D054598:Blue Cross Blue Shield Insurance Plans; D002648:Child; D002675:Child, Preschool; D025063:Chromosome Disorders / Q000235:genetics*; D055028:Comparative Genomic Hybridization / Q000379:methods*; D002658:Developmental Disabilities / Q000175:diagnosis / Q000235:genetics*; D005820:Genetic Testing / Q000379:methods*; D014644:Genetic Variation; D015894:Genome, Human / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D008607:Intellectual Disability / Q000175:diagnosis / Q000235:genetics*; D007621:Karyotyping / Q000379:methods; D017064:Process Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration